Based on this result, 12 bacterial strains were selected and named as 4A, 52G, 31C, 42C, 42D, 42E, 5D, 31A, 28E, 2B, 33C, and 23B.
Six bacterial strains were selected for this study: Escherichia coli, Staphylococcus aureus, Yersinia enterocolitica, Listeria monocytogenes, Klebsiella pneumonia and Bacillus subtilis.
The following bacterial strains were selected: Escherichia coli ATCC 25922, Staphyloccocus aureus ATCC 25923, Bacillus pumilus ATCC 27142, Klebsiella pneumonia ATCC 13883, Bacillus subtilis IFO 3457, Salmonella typhimurium B11, Pseudomonas aeruginosa ATCC 27853.
To determine the biocidal potential of CS-AuNP films, two representative bacterial strains were selected.
Out of nine LAB isolates, three bacterial strains were selected on the basis of specific FAE activity (Table 1).
To analyze the detailed error types of the unreliable types, 30 validated bacterial strains were selected (6 reliable, 18 marginal and 6 unreliable).
The top 10 hit materials with the lowest observed bacterial attachment for all three strains were selected for further study.
Strains were selected to represent bacterial families of which the members are most frequently isolated in clinical samples: Escherichia coli (E. coli) representing the Enterobacteriaceae, Pseudomonas aeruginosa (P. aeruginosa) representing the non-fermenting bacteria, and Staphylococcus aureus (S. aureus) representing the Staphylococci.
Because of the large number of strains for some bacterial species, only one strain was selected for each species.
As a form to evaluate the proteolytic abilities of the 70 bacterial strains that were selected for their cellulolytic ability, it was used a high throughput screening methodology based on the use of FRET peptide probe (Oliveira et al. 2012), under three pHs, including neutral, acidic and alkaline conditions.
Analyzes to identify the bacterial strains that were selected by investigation of their enzymatic abilities were also developed, allowing their phylogenetic characterization at genus level.
